FLUKANEX SUSPENSION
LEVAMIZOLE HYDROCHLORIDE AND RAFOXANIDE
What it does
Levamisole is a medication used to treat infections caused by certain worms and to boost the immune system.
Commonly used for: worm infections (helminthiasis), immune system support
Read more in plain English ↓Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.
Ask about this medicine
Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.
Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.
Source this medicineRegistration & product details
Source: Pharmacy and Poisons Board · fetched 2026-01-28 20:49:17 · updated 2026-07-26 11:39:46
About levamizole
Levamisole is a medication used to treat infections caused by certain worms and to boost the immune system.
What it treats
- worm infections (helminthiasis)
- immune system support
How it works
Levamisole helps to kill worms in the body and also enhances the body's immune response.
Who it's for
It is used for people with specific worm infections and those needing immune system support.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
About rafoxanide
Rafoxanide is a medication used to treat certain infections caused by parasites.
What it treats
- parasite infections (such as fascioliasis)
- liver fluke disease
How it works
Rafoxanide works by attacking and killing the parasites that cause the infection.
Who it's for
This medication is typically used for individuals who have been diagnosed with specific parasitic infections.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
Clinical monograph: levamizole
Levamisole is an anthelmintic agent primarily used for the treatment of various parasitic worm infections, particularly in veterinary medicine and in certain human conditions. It is a synthetic derivative of imidazothiazole and works by disrupting the metabolism of helminths. Additionally, it has been used as an immune-modulating agent in certain diseases, including colorectal cancer and autoimmune disorders.
Indications
- Ascariasis
- Hookworm infection
- Strongyloidiasis
- Immunomodulation in colorectal cancer
- Autoimmune diseases
Dosage
Children: Refer to the BNF for Children for specific paediatric dosing recommendations.
Adults: Refer to the BNF for specific adult dosing recommendations.
Mechanism of action
Levamisole acts by binding to nicotinic acetylcholine receptors on the muscle cells of helminths, leading to paralysis and expulsion of the parasites. It is also thought to enhance T-cell function and boost the immune system, particularly in the context of cancer therapy.
Pharmacodynamics
Levamisole exhibits its anthelmintic effects through neuromuscular paralysis of the parasites, which prevents them from attaching to the intestinal wall and allows for their elimination. Its immunomodulatory effects are attributed to its ability to enhance T-cell proliferation and stimulate interferon production, thus improving the host's immune response.
Pharmacokinetics
Levamisole is well absorbed after oral administration, with peak plasma concentrations occurring within 1 to 2 hours. It undergoes extensive hepatic metabolism, primarily through cytochrome P450 enzymes, and has a half-life of approximately 3 to 5 hours. The metabolites are primarily excreted via the urine. Food intake does not significantly affect its absorption.
Contra-indications
- Hypersensitivity to levamisole or any of its components
- Severe immunosuppression
- History of agranulocytosis
Adverse effects
- Nausea
- Vomiting
- Diarrhea
- Abdominal pain
- Rash
- Agranulocytosis
- Hepatotoxicity
- CNS effects such as dizziness and headache
Interactions
- Increased risk of agranulocytosis when used with other myelosuppressive agents
- Possible interaction with warfarin, increasing anticoagulant effect
- Caution with concurrent use of drugs that affect the liver
Precautions
- Use with caution in patients with liver impairment
- Monitor blood counts during therapy due to risk of agranulocytosis
- Consider potential drug interactions before initiating therapy
Pregnancy
Levamisole is classified as category C. Use is not recommended unless the potential benefit outweighs the potential risk to the fetus.
Breast-feeding
It is not known whether levamisole is excreted in human milk. Caution should be exercised when administering to nursing mothers.
Storage
Store at room temperature, away from light and moisture. Keep out of reach of children.
Formulations
- Tablets
- Oral suspension
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.
Clinical monograph: rafoxanide
BNF-referencedRafoxanide is an anthelmintic and anti-inflammatory agent primarily used in veterinary medicine for the treatment of parasitic infections in livestock. It is effective against various species of flukes and some nematodes. Rafoxanide acts by disrupting the energy metabolism of parasites, leading to their death. The compound is known for its broad-spectrum efficacy against trematodes and is used in the control of fasciolosis, particularly in cattle and sheep.
Indications
- Fasciolosis
- Liver fluke infections
- Parasitic infections in livestock
Dosage
Children: Refer to the BNF for Children for specific dosing information.
Adults: Refer to the BNF for specific dosing information.
Mechanism of action
Rafoxanide functions by inhibiting the succinate dehydrogenase enzyme in the parasite's mitochondria, which disrupts the energy production process. This ultimately leads to a depletion of ATP in the parasite, resulting in its death. The drug has a high affinity for the parasite's mitochondrial membranes, making it effective against trematodes and some nematodes.
Pharmacodynamics
Rafoxanide exhibits a rapid onset of action against susceptible parasites. The drug’s effectiveness is influenced by its lipophilicity, which aids in its absorption and distribution within the host. It demonstrates a high level of activity against adult and juvenile stages of flukes, providing a therapeutic benefit in the management of trematodiasis.
Pharmacokinetics
Rafoxanide is well absorbed after administration and achieves peak plasma concentrations relatively quickly. The drug is extensively metabolized in the liver, with metabolites being primarily excreted via the bile. Its elimination half-life allows for dosing at intervals that effectively manage parasitic infections. The pharmacokinetics may vary based on the animal species and health status.
Pregnancy
There is limited data on the use of rafoxanide in pregnancy. Caution is advised.
Breast-feeding
It is not known if rafoxanide is excreted in human milk. Caution is advised.
Storage
Store in a cool, dry place away from direct sunlight.
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.
Molecular reference: rafoxanide
PubChem CID 31475Molecular formula: C19H11Cl2I2NO3
Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.
This drug in other countries
The same active ingredient registered across other registries we cover - including different brands.